Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Banco Bilbao Vizcaya Argentaria SA (BBVA) vs Invesco Ltd. (IVZ) Price & Performance

Banco Bilbao Vizcaya Argentaria SATrade
Invesco Ltd.Trade

Price performance (Past 24H)

Key statistics

Banco Bilbao Vizcaya Argentaria SA vs Invesco Ltd. — how do they compare? Banco Bilbao Vizcaya Argentaria SA trades at $28.6 (market cap $157.51B), while Invesco Ltd. trades at $31.16 (market cap $13.85B). The key difference: Banco Bilbao Vizcaya Argentaria SA is far larger — about 11.4× Invesco Ltd.'s market cap, and Banco Bilbao Vizcaya Argentaria SA pays the higher dividend (3.8%). Which is the better fit depends on your goals.

BBVAIVZ
Market Cap
$157.51B$13.85B
Sector
FinancialsFinancials
52-Week High
$28.50$32.01
52-Week Low
$17.96$20.67
Dividend Yield
3.8%2.74%
Enterprise Value
$24.01B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Banco Bilbao Vizcaya Argentaria SA

Despite its Spanish origins, BBVA generates three quarters of its profits in emerging markets, especially Mexico that contributes nearly half of BBVA's net profit. BBVA is overwhelmingly a retail and commercial bank with corporate and investment banking forming a smaller part of the overall business.

Read more on BBVA

About Invesco Ltd.

Invesco provides investment-management services to retail (65% of managed assets) and institutional (35%) clients. At the end of August 2022, the firm had $1.416 trillion in assets under management spread among its equity (47% of AUM), balanced (5%), fixed-income (22%), alternative investment (14%), and money market (12%) operations. Passive products account for 32% of Invesco's total AUM, including 56% of the company's equity operations and 13% of its fixed-income platform. Invesco's U.S. retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside the U.S., with close to one third of its AUM sourced from Canada (2%), the U.K. (4%), continental Europe (11%), and Asia (15%).

Read more on IVZ